Newsfiscal.ai
Mizuho Securities Lowers Price Target for Zentalis Pharmaceuticals
· Published
Article summary
Mizuho Securities has adjusted its price target for Zentalis Pharmaceuticals, Inc., lowering it from $8 to $7.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…